Pomerantz LLP Reminds Shareholders With Losses in Cytokinetics, Incorporate of Legal Deadlines – CYTK
NEW YORK CITY, NY / ACCESS Newswire / November 14, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Cytokinetics, Incorporate ("Cytokinetics" or the "Company") (NASDAQ:CYTK).â?¯â?¯ Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged […]